(Q40833190)

24 September 2017

title

The possible involvement of CXCR4 in the inhibition of HIV-1 infection mediated by DP178/gp41. (English)

1 reference

24 September 2017

3

1 reference

24 September 2017

Y Xu

1

1 reference

24 September 2017

X Zhang

series ordinal

2

1 reference

24 September 2017

T Hattori

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 December 2000

1 reference

24 September 2017

1 reference

24 September 2017

volume

487

1 reference

24 September 2017

issue

2

1 reference

24 September 2017

page(s)

185-188

1 reference

The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Identification of a major co-receptor for primary isolates of HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Core structure of gp41 from the HIV envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Atomic structure of the ectodomain from HIV-1 gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Capture of an early fusion-active conformation of HIV-1 gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Propensity for a leucine zipper-like domain of human immunodeficiency virus type 1 gp41 to form oligomers correlates with a role in virus-induced fusion rather than assembly of the glycoprotein complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Marked increase in anti-HIV activity, as well as inhibitory activity against HIV entry mediated by CXCR4, linked to enhancement of the binding ability of tachyplesin analogs to CXCR4

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Inhibition of infection of incoming HIV-1 virus by RNA-cleaving DNA enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

CD4-independent infection by HIV-2 is mediated by fusin/CXCR4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Recognition by human monoclonal antibodies of free and complexed peptides representing the prefusogenic and fusogenic forms of human immunodeficiency virus type 1 gp41

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Human monoclonal antibody 98-6 reacts with the fusogenic form of gp41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

The bis-azo compound FP-21399 inhibits HIV-1 replication by preventing viral entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Selective CXCR4 antagonism by Tat: implications for in vivo expansion of coreceptor use by HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Rapid development of isolate-specific neutralizing antibodies after primary HIV-1 infection and consequent emergence of virus variants which resist neutralization by autologous sera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone

21 January 2018

2 references

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.

1 reference

https://api.crossref.org/works/10.1016%2FS0014-5793%2800%2902336-X

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0014-5793(00)02336-X

1 reference

24 September 2017

1 reference